Anavex Life Sciences (AVXL) Non-cash Items (2014 - 2025)
Anavex Life Sciences recorded quarterly Non-cash Items of $4.8 million in Q4 2025, down 99.99% quarter-over-quarter from $39.7 billion in Q3 2025, and down 29.41% year-over-year from $6.8 million in Q4 2024.
Anavex Life Sciences' Non-cash Items history runs 12 years deep, the most recent figure standing at $4.8 million for Q4 2025.
- In Q4 2025, Non-cash Items fell 29.41% year-over-year to $4.8 million; the TTM figure through Dec 2025 stood at $4.8 million (down 29.41% YoY), while the FY2025 annual figure was $10.4 million, up 5.12% from the prior year.
- Non-cash Items came in at $4.8 million for Q4 2025 at Anavex Life Sciences, down from $39.7 billion in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $39.7 billion in Q3 2025 to a low of $4.8 million in Q4 2025.
- A 5-year average of $2.1 billion and a median of $10.3 million in 2025 frame the typical range for Non-cash Items.
- Across the five-year window, Non-cash Items tumbled 64.2% in 2023 and soared 250854.96% in 2025, its largest moves.
- Anavex Life Sciences' Non-cash Items stood at $18.2 million in 2021, then dropped by 10.07% to $16.3 million in 2022, then tumbled by 40.86% to $9.7 million in 2023, then slipped by 29.63% to $6.8 million in 2024, then slipped by 29.41% to $4.8 million in 2025.
- According to Business Quant data, Non-cash Items over the past three periods registered $4.8 million, $39.7 billion, and $10.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.80 Mn |
| Dec 31, 2025 | 4.80 Mn |
| Sep 30, 2025 | 39.72 Bn |
| Sep 30, 2025 | 39.72 Bn |
| Jun 30, 2025 | 10.54 Mn |
| Jun 30, 2025 | 10.54 Mn |
| Mar 31, 2025 | 10.35 Mn |
| Mar 31, 2025 | 10.35 Mn |
| Dec 31, 2024 | 6.80 Mn |
| Dec 31, 2024 | 6.80 Mn |
| Sep 30, 2024 | 15.83 Mn |
| Sep 30, 2024 | 15.83 Mn |
| Mar 31, 2024 | 9.96 Mn |
| Mar 31, 2024 | 9.96 Mn |
| Dec 31, 2023 | 9.66 Mn |
| Dec 31, 2023 | 9.66 Mn |
| Sep 30, 2023 | 22.29 Mn |
| Sep 30, 2023 | 22.29 Mn |
| Jun 30, 2023 | 10.03 Mn |
| Jun 30, 2023 | 10.03 Mn |
| Mar 31, 2023 | 21.78 Mn |
| Mar 31, 2023 | 21.78 Mn |
| Dec 31, 2022 | 16.34 Mn |
| Dec 31, 2022 | 16.34 Mn |
| Sep 30, 2022 | 62.27 Mn |
| Sep 30, 2022 | 62.27 Mn |
| Jun 30, 2022 | 8.56 Mn |
| Jun 30, 2022 | 8.56 Mn |
| Mar 31, 2022 | 8.20 Mn |
| Mar 31, 2022 | 8.20 Mn |
| Dec 31, 2021 | 18.17 Mn |
| Dec 31, 2021 | 18.17 Mn |
| Sep 30, 2021 | 140.13 Mn |
| Sep 30, 2021 | 140.13 Mn |
| Jun 30, 2021 | 7.93 Mn |
| Jun 30, 2021 | 7.93 Mn |
| Mar 31, 2021 | 7.09 Mn |
| Mar 31, 2021 | 7.09 Mn |
| Dec 31, 2020 | 8.19 Mn |
| Dec 31, 2020 | 8.19 Mn |
| Sep 30, 2020 | 14.98 Mn |
| Sep 30, 2020 | 14.98 Mn |
| Jun 30, 2020 | 17.82 Mn |
| Jun 30, 2020 | 17.82 Mn |
| Mar 31, 2020 | 4.52 Mn |
| Mar 31, 2020 | 4.52 Mn |
| Dec 31, 2019 | 5.88 Mn |
| Dec 31, 2019 | 5.88 Mn |
| Sep 30, 2019 | 4.12 Mn |
| Sep 30, 2019 | 4.12 Mn |
| Jun 30, 2019 | 5.46 Mn |
| Jun 30, 2019 | 5.46 Mn |
| Mar 31, 2019 | 5.24 Mn |
| Mar 31, 2019 | 5.24 Mn |
| Dec 31, 2018 | 4.36 Mn |
| Dec 31, 2018 | 4.36 Mn |
| Sep 30, 2018 | 2.35 Mn |
| Sep 30, 2018 | 2.35 Mn |
| Jun 30, 2018 | 162,500.00 |
| Jun 30, 2018 | 162,500.00 |
| Mar 31, 2018 | 3.78 Mn |
| Mar 31, 2018 | 3.78 Mn |
| Dec 31, 2017 | 1.65 Mn |
| Dec 31, 2017 | 1.65 Mn |
| Sep 30, 2017 | 5.28 Mn |
| Sep 30, 2017 | 5.28 Mn |
| Jun 30, 2017 | 630.00 |
| Jun 30, 2017 | 630.00 |
| Mar 31, 2017 | 2.61 Mn |
| Mar 31, 2017 | 2.61 Mn |
| Dec 31, 2016 | 36,000.00 |
| Dec 31, 2016 | 36,000.00 |
| Sep 30, 2016 | 2.29 Mn |
| Sep 30, 2016 | 2.29 Mn |
| Jun 30, 2016 | 217,500.00 |
| Jun 30, 2016 | 217,500.00 |
| Mar 31, 2016 | 5.57 Mn |
| Mar 31, 2016 | 5.57 Mn |
| Dec 31, 2015 | 843,107.00 |
| Dec 31, 2015 | 843,107.00 |
| Sep 30, 2015 | 825,002.00 |
| Sep 30, 2015 | 825,002.00 |
| Sep 30, 2014 | 525,000.00 |
| Sep 30, 2014 | 525,000.00 |